Nearly 20 million people with epilepsy suffer from seizures that are poorly controlled by
medication. 1 For many of these individuals, seizures originate from 1 or more focal areas …

A significant proportion of epilepsy patients is medically refractory, 1, 2 and apart from those
who are candidates for resective surgery, most will continue to have disabling seizures for …

Direct electrical stimulation of the brain is an increasingly popular means of treating
refractory epilepsy. 1 Although there has been moderate success in human trials, the rate of …

One-third of people with epilepsy have generalized onset seizures, 1, 2 which appear to
begin in both hemispheres simultaneously on scalp electroencephalography (EEG). This …

Epilepsy is the fourth most common neurologic disorder. In 2015, the Centers for Disease
Control and Prevention estimated that there are at least 3.4 million people with epilepsy in …

Neurostimulation for Epilepsy sive neurostimulation is initiated only when an algorithm
detects preprogrammed features of the EEG. Modern neurosurgeons employ stereotactic …

The first uses of electrical stimulation applied to the human brain were documented in the
late nineteenth and early twentieth century by neurosurgical pioneers including Victor …

Object Epilepsy surgery is at the cusp of a transformation due to the convergence of
advancements in multiple technologies. Emerging neuromodulatory therapies offer the …

The main aim of presurgical assessment in patients with epilepsy or brain lesions is to
achieve good seizure or tumor control, while ensuring preservation of functional areas to …

Mountain View, California) is the first and currently only United States Food and Drug
Administration (FDA)-approved closed-loop, or responsive, implantable neurostimulator …